Table 3.

Adjusted odds ratios of outcomes according to AIP in stroke subtypes.

Stroke subtypes	AIP
	Quartile 1 < -0.10	Quartile 2 −0.10 to 0.08	Quartile 3 0.08–0.26	Quartile 4 ≥0.26	p# trend
No. of cases	366	366	366	365
Large artery atherosclerosis
Model 1*	1	1.29 (0.77–2.18)	1.58 (1.32–1.87)	1.90 (1.53–2.62)	0.002
Model 2**	1	1.13 (1.03–1.58)	2.43 (2.15–3.20)	2.94 (2.36–3.46)	0.001
Model 3***	1	1.45 (1.26–1.78)	1.70 (1.43–2.16)	1.77 (1.45–2.20)	0.007
Cardioembolic
Model 1*	1	0.12 (0.01–1.03)	0.18 (0.02–1.65)	0.21 (0.02–1.87)	0.115
Model 2**	1	0.17 (0.02–1.74)	1.51 (0.33–6.89)	0.28 (0.03–2.79)	0.157
Model 3***	1	0.55 (0.18–3.63)	4.11 (1.02–16.4)	0.93 (0.21–4.21)	0.114
Small-artery occlusion
Model 1*	1	0.77 (0.34–1.76)	1.05 (0.48–2.26)	0.50 (0.19–1.31)	0.439
Model 2**	1	0.91 (0.12–6.67)	1.51 (0.24–9.23)	0.58 (0.05–6.48)	0.859
Model 3***	1	0.51 (0.25–1.03)	0.85 (0.44–1.63)	0.74 (0.37–1.48)	0.311
Other or unknown cause
Model 1*	1	1.25 (0.51–3.06)	1.27 (0.49–3.25)	0.75 (0.29–1.92)	0.672
Model 2**	1	1.91 (0.44–8.31)	1.86 (0.39–8.66)	0.31 (0.03–3.02)	0.343
Model 3***	1	1.62 (0.78–3.33)	1.41 (0.65–3.03)	0.81 (0.38–1.71)	0.241

^#Adjustment for age, gender, and baseline NIHSS; history of lipid-lowering therapy; reperfusion therapy; history of atrial fibrillation; and history of diabetes mellitus, glucose, TC, and LDL-C.

^*Death and major disability (mRS, 3–6).

^**Death (mRS = 6).

^***Death or disability (mRS, 2–6).

AIP, atherogenic index of plasma.